Compulsory licensing threat in Europe requires vigilance from pharma patent owners

@IAM_magazine IBM's evolution is set for another step change with looming spin out but impact maybe more muted on IP front… https://t.co/yvXpIGhD1u Read more

@IAM_magazine Group of leading academics say Humira patent thicketing antitrust issues must be looked at again:… https://t.co/c4rkMjWmlT Read more

@IAM_magazine RT @jwschindler: It looks like Toyota is finding plenty of interest in its hybrid tech in China, more than a year after it announced royalt… Read more

@IAM_magazine RT @jwschindler: Ericsson's IP licensing practices are the subject of an ongoing anti-monopoly probe by China's State Administration for Ma… Read more